David A. Cory

Insider Reports History

Location
Palo Alto, CA
Signature
/s/ Sriram Ryali, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David A. Cory:

Company Role Class Num Shares Value Price $ Report Date Ownership
Eiger BioPharmaceuticals, Inc. President and CEO, Director Common Stock 169,183 $50,366 $0.2977 11 Mar 2022 Direct
Eiger BioPharmaceuticals, Inc. President and CEO, Director Stock Option (Right to Buy) 281,000 11 Mar 2022 Direct

Insider Reports Filed by David A. Cory

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000114036122009256-cory-david-a-2022-03-11 Eiger BioPharmaceuticals, Inc. 11 Mar 2022 2 $0 4 President and CEO, Director 11 Mar 2022, 20:06
/report/000156761921014219-cory-david-a-2021-07-29 Eiger BioPharmaceuticals, Inc. 29 Jul 2021 1 $0 4 President and CEO, Director 30 Jul 2021, 16:29